Histological and immunohistochemical study of composite neuroendocrine-exocrine carcinomas of the stomach

Journal of Medical Investigation

Volumn 52, Issue 3-4, 2005, Pages 191-202

  Rayhan, Nasim ^a   Sano, Toshiaki ^a   Qian, Zhi Rong ^a   Obari, Abdul Kader ^a   Hirokawa, Mitsuyoshi ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Composite neuroendocrine exocrine carcinoma; Immunohistochemistry; NCAM; Stomach; Tumorigenesis

Indexed keywords

GHRELIN; NERVE CELL ADHESION MOLECULE; SMAD4 PROTEIN; DNA BINDING PROTEIN; PEPTIDE HORMONE; SMAD4 PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN;

ADULT; AGED; ARTICLE; CELL DIFFERENTIATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; EXOCRINE CELL; FEMALE; GASTROINTESTINAL TUMOR; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; NEUROENDOCRINE EXOCRINE CARCINOMA; NEUROENDOCRINE TUMOR; PLURIPOTENT STEM CELL; STOMACH CARCINOMA; ADENOCARCINOMA; CARCINOMA; METABOLISM; MIDDLE AGED; PATHOLOGY; STOMACH TUMOR;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; CARCINOMA, NEUROENDOCRINE; DNA-BINDING PROTEINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEURAL CELL ADHESION MOLECULES; PEPTIDE HORMONES; SMAD4 PROTEIN; STOMACH NEOPLASMS; TRANS-ACTIVATORS;

EID: 27244443237     PISSN: 13431420     EISSN: None     Source Type: Journal    
DOI: 10.2152/jmi.52.191     Document Type: Article

References (43)

1. Lewin K: Carcinoid tumors and the mixed (composite) glandular-endocrine cell carcinomas. Am J Surg Pathol 11(suppl): 71-86, 1987
2. Solcia E, Kloppel G, Sobin LH: Histological typing of neuroendocrine tumors. International histological classification of tumors. World Health Organization, Berlin Heidelberg New York, 2000
3. Capella C, Rosa SL, Uccella S, Billo P, Carnaggia M: Mixed endocrine-exocrine tumors of the gastrointestinal tract. Semin Diag Pathol 17: 91-103, 2000
4. Azzopardi JG, Pollock DJ: Argentaffin and argyrophil cells in gastric carcinoma J Pathol Bacterol 86: 443-451, 1963
5. Ooi A, Mai M, Ogino T, Ueda H, Kitamura T, Takahashi Y, Kawahara E, Nakanishi I: Endocrine differentiation of gastric adenocarcinoma. The prevalence as evaluated by immunoreative chromogranin A and its biologic significances. Cancer 62: 1092-1104, 1988
6. Matsui K, Kitagawa M, Miwa A, Kuroda Y, Tsuji M: Small cell carcinoma of the stomach: A clininicopathological study of 17 cases. Am J Gastrienterol 86: 1167-1175, 1991
7. Soga J, Tazawa K, Aizawa O, Wada K, Tuto T: Argentaffin cell adenocarcinoma of stomach: An atypical carcinoid ? Cancer 28: 999-1003, 1971
8. Murayama H, Imai T, Kikuchi M: Solid carcinomas of the stomach. A combined histological, light and electron microscopic study. Cancer 51: 1673-1681, 1983
9. Yamashina M, Flinner RA: Concurrent occurrence of adenocarcinoma and carcinoid tumor of stomach. A composite tumor or collision tumors? Am J Clin Pathol 83: 233-236, 1985
10. Cruso ML, Pilato FP, D'adda T, Baggy MT, Fucci L, Valentini AM, Lacatena M, Bordi Cesare: Composite carcinoid-adenocarcinoma of the stomach associated with multiple gastric carcinoids and nonantral atrophy. Cancer 64: 1534-1539, 1989
11. Yang GC, Rotterdam H: Mixed (composite) glandular-endocrine cell carcinoma of the stomach. Report of a case and review of the literature. Pathol 15: 592-598, 1991
12. Rassidakis GZ, Delladetsima JK, Letsos SP, Polyzos A, Yannopoulos A: Hepatoid adenocarcinoma of the stomach with extensive neuroendocrine differentiation and a coexisting carcinoid tumour. Histopathology 33: 186-188, 1998
13. Cavallaro U, Christofori G: Cell adhesion in tumor invasion and metastasis: Loss of the glue is not enough. Biochim Biophys Acta 1552: 39-45, 2001
14. Huerta S, Srivatsan ES, Venkatesan N, Peters J, Moatamed F, Renner S, Livingston EH: Alternative mRNA splicing in colon cancer causes loss of expression of neural cell adhesion molecule. Surgery 130: 834-843, 2001
15. Roesler J, Srivatsan E, Moatamed F, Peters J, Livingston EH: Tumor suppressor activity of neural cell adhesion molecule in colon carcinoma. Am J Surg 174: 251-257, 1997
16. Rindi G, Savio A, Torsello A, Michele Z, Locatelli V, Cocchi D, Paolotti D, Solcia E: Ghrelin expression in gut endocrine growths. Histochem Cell Biol 117: 521-525, 2002
17. Papotti M, Cassoni P, Volante M, Deghenghi R, Muccioli G, Ghigo E: Ghrelin producing endocrine tumors of the stomach and intestine. J Clin Endocrinol Metab 86: 5052-5059, 2001
18. Hahn SA, Hoque AT, Moskaluk CA, da Costa LT, Schutte M, Rozenblum E, Seymour AB, Weinstein CL, Yeo CJ, Hruban RH, Kern SE: Homozygous deletion map at 18q21.1 in pancreatic cancer. Cancer Res 56: 490-494, 1996
19. Hahn SA, Schutte M, Hoque AT, Moskaluk CA, da Costa LT, Rozenblum E, Weinstein CL, Fischer A, Yeo CJ, Hruban RH, Kern SE: DPC4, a candidate tumor suppressor gene at human chromosome 18 q 21.1. Science 271: 350-353, 1996
20. Perren A, Saremaslani P, Schmid S, Bonvin C, Locher T, Roth J, Roth J, Heitz PU, Komminoth P: DPC4/Smad4: no mutations, rare allelic imbalances, and retained protein expression in pancreatic endocrine tumors. Diagn Mol Pathol 12: 181-186, 2003
21. Lollgen RM, Hessman O, Szabo E, Westin G, Akerstrom G: Chromosome 18 deletions are common events in classical midgut carcinoid tumors. Int J Cancer 92: 812-815, 2001
22. Scarpa A, Orlandini S, Moore PS, Lemoine NR, Beghelli S, Baron A Falconi M, Zamboni G: DPC4 is expressed in virtually all primary and metastatic pancreatic endocrine carcinomas. Virchows Arch 440: 155-159, 2002
23. Lantuejoul S, Moro D, Michalides RJ, Brambilla C, Brambilla E: Neural cell adhesion molecules (NCAM) and NCAM-PSA expression in neuroendocrine lung tumors. Am J Surg Pathol 22: 1267-1276, 1998
24. Kibbelaar RE, Moolenaar KE, Michalides RJ, Van Bodegom PC, Vanderschueren RG, Wagenaar SS, Dingemans KP, Bitter-Suermann D, Dalesio O, Van Zandwijk N, Mooi WJ: Neural cell adhesion molecule expression, neuroendocrine differentiation and prognosis in lung carcinoma. Eur J Cancer 27: 431-435, 1991
25. Aletsee-Ufrecht MC, Langley K, Rotsch M, Havemann K, Gratzl M. NCAM: a surface marker for human small cell lung cancer cells. FEBS Lett 267: 295-300, 1990
26. Nguyen VN, Mirejovsky T, Melinova L, Mandys V: CD44 and its v6 spliced variant in lung carcinomas: relation to NCAM, CEA, EMA and UP1 and prognostic significance. Neoplasma 47: 400-408, 2000
27. Tezel E, Nagasaka T, Nomoto S, Sugimoto H, Nakao A: Neuroendocrine-like differentiation in patients with pancreatic carcinoma. Cancer 89: 2230-2236, 2000
28. Seki H, Koyama K, Tanaka J, Sato Y, Umezawa A: Neural cell adhesion molecule and perineural invasion in gallbladder cancer. J Surg Oncol 58: 97-100, 1995
29. Zoltowska A, Stepinski J, Lewko B, Serkies K, Zamorska B, Roszkiewicz A, Izycka-Swieszewska E, Kruszewski WJ: Neural cell adhesion molecule in breast, colon and lung carcinomas. Arch Immunol Ther Exp (Warsz) 49: 171-174, 2001
30. Asayama Y, Aishima S, Taguchi K, Sugimachi K, Matsuura S, Masuda K, Tsuneyoshi M: Coexpression of neural cell adhesion molecules and bcl-2 in intrahepatic cholangiocarcinoma originated from viral hepatitis: relationship to atypical reactive bile ductule. Pathol Int 52: 300-306, 2002
31. Kenmotsu M, Gouchi A, Maruo Y, Murashima N, Hiramoto Y, Iwagaki H, Orita K: [The expression of neural cell adhesion molecule (NCAM), neural invasion and recurrence patterns in rectal cancer-a study using anti-NACM (neural cell adhesion molecule) antibody] Nippon Geka Gakkai Zasshi 95 (in Japanese): 66-70, 1994
32. Brezicka FT, Oiling S, Bergman B, Berggren H, Engstrom CP, Hammarstrom S, Holmgren J, Larsson S, Lindholm L: Coexpression of ganglioside antigen Fuc-GM1, neural-cell adhesion molecule, carcinoembryonic antigen, and carbohydrate tumor-associated antigen CA 50 in lung cancer. Tumour Biol 13: 308-315, 1992
33. Lantuejoul S, Laverriere MH, Sturm N, Moro D, Frey G, Brambilla C, Brambilla E: NCAM (neural cell adhesion molecules) expression in malignant mesotheliomas. Hum Pathol 31: 415-421, 2000
34. Maitra A, Krueger JE, Tascilar M, Offerhaus GJ, Angeles-Angeles A, Klimstra DS, Hruban RH, Albores-Saavedra J: Carcinoid tumors of the extrahepatic bile ducts: a study of seven cases. Am J Surg Pathol 24: 1501-1510, 2000
35. Bartsch D, Hahn SA, Danichevski KD, Ramaswamy A Bastian D, Galehdari H, Barth, P, Schmiegel W, Simon B, Rofhmund M: Mutations of the DPC4/Smad4 gene in neuroendocrine pancreatic tumors. Oncogene 18: 2367-2371, 1999
36. Lundwvist M, Wilander E: Exocrine and endocrine differentiation in small intestinal adenocarcinomas. Arch Pathol Micrib Scand Sect A 91: 469-474, 1983
37. Adhikari D, Conte C, Eskreis D, Urmacher C, Ellen K: Combined adenocarcinoma and carcinoid tumor in atrophic gastritis. Ann Clin Lab Sci 32: 422-427, 2002
38. Lyda M, Fenoglio-preiser CM: Adenoma-carcinoid tumors of the colon. Arch Pathol lab Med 122: 262-265, 1998
39. Lattes R, Grossi C: Carcinoid tumors of the stomach. Cancer 9: 698-711, 1956
40. Kim KM, Kim MJ, Cho BK, Choi SW, Rhyu MG: Genetic evidence for the multi-step progression of mixed glandular-neuroendocrine gastric carcinomas. Virchows Arch 400: 85-93, 2002
41. Wheeler DA, Chandrasoma P, Carriere CA, Schwinn CP: Cytologic diagnosis of gastric composite adenocarcinoma-carcinoid. Acta Cytol 28: 706-708, 1983
42. Bates HR, Belter LF: Composite carcinoid tumor (argentaffinoma- adenocarcinoma) of the colon. Dis Colon Rectum 10: 467-470, 1967
43. Vortmeyer AO, Lubensky IA, Merino MJ, Wang CY, Pham T, Furth EE, Zhuang Z: Concordance of genetic alteration in poorly differentiated colorectal carcinomas and associated adenocarcinomas. J Natl Cancer Inst 89: 1448-1453, 1997